At 11:20 a.m. this Thursday, the Ibovespa was up 0.75% at 168,817.39 points, after opening 0.17% higher at 167,841.95 points. Among individual highlights, Oncoclínicas (ONCO3) was up 10.39% at R$ 0.85, and Construtora Tenda (TEND3) was down 11.24% at R$ 17.53. In rounded terms, ONCO3 was up 10.4% and TEND3 was down 11.2%.

Gainers: besides ONCO3, the biggest gains include:

  • Grupo Pão de Açúcar - GPA (PCAR3): R$ 2.53 | +10.00%
  • Iochpe-Maxion (MYPK3): R$ 9.38 | +9.45%
  • HBR Realty (HBRE3): R$ 1.95 | +8.94%
  • Cosan (CSAN3): R$ 2.60 | +8.79%

In the case of ONCO3, Oncoclínicas secured creditor adhesion of R$ 4.3 billion in the restructuring, equivalent to 74.6% of the credit base of about R$ 5.8 billion, excluding intercompany. PCAR3 reported a loss of R$ 220 million from continuing operations in 3Q26, with Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) of R$ 482 million, up 16.9%. MYPK3 posted a loss of R$ 16 million in 3Q26, with revenue of R$ 4.4 billion (+15.8%) and adjusted EBITDA of R$ 480.5 million (+22.6%). HBRE3 announced the sale of assets to an SPX fund for R$ 937.7 million, of which R$ 562.6 million will be paid in cash at closing, expected by November 11.

Decliners: after TEND3, the biggest drops are:

  • Biomm (BIOM3): R$ 5.89 | -6.95%
  • Méliuz (CASH3): R$ 4.05 | -6.47%
  • CSN Mineração (CMIN3): R$ 4.92 | -6.11%
  • Azevedo & Travassos Energia (AZTE3): R$ 0.75 | -2.60%

Tenda posted a profit of R$ 57.3 million in 3Q26; excluding the Swap effect, profit is R$ 106.4 million, up 3.7% from 3Q25. Méliuz reported a profit of R$ 113.7 million in the quarter, with revenue of R$ 96.1 million (-22.3%) and adjusted EBITDA of R$ 17.0 million (-37.7%). AZTE3, meanwhile, approved a capital increase of up to R$ 31.6 million, with shares at R$ 0.79 and a subscription period from November 9 to December 8, 2026.

Also read:

Tags:
ONCO3PCAR3MYPK3TEND3BIOM3CASH3IbovespaStock MarketB3